FDA Authorizes Marketing of IpsiHand System
Recently, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to…
Recently, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to…
Current research from the University of Nottingham has identified that more than half of the subjects taking statins did not optimally reduce their cholesterol, placing…
Patients with atrial fibrillation (AF) “particularly overestimated” the clear dangers of stroke and death. This poor comprehension of the risks can affect whether they take…